BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2024 8:56:47 AM | Browse: 64 | Download: 240
 |
Received |
|
2024-01-03 01:26 |
|
Peer-Review Started |
|
2024-01-03 01:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-10 05:57 |
|
Revised |
|
2024-04-27 16:23 |
|
Second Decision |
|
2024-05-20 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-05-20 08:23 |
|
Articles in Press |
|
2024-05-20 08:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-29 08:25 |
|
Publish the Manuscript Online |
|
2024-06-24 08:56 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Editorial |
| Article Title |
New targets for cancer promotion and therapy in gliomas: Scinderin
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xi Wang and Lian-Xiang Luo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Lian-Xiang Luo, PhD, Adjunct Associate Professor, The Marine Biomedical Research Institute, Guangdong Medical University, No. 2 Wenming East Road, Zhanjiang 524000, Guangdong Province, China. luolianxiang321@gdmu.edu.cn |
| Key Words |
Glioma; Scinderin; Actin cytoskeleton; RhoA/FAK signaling; 1p/19q co-deletion |
| Core Tip |
The role of scinderin (SCIN) in cancer progression has been studied, but its role in glioma remains unknown. Lin et al found that the expression level of SCIN mRNA was positively correlated with the tumor grade of glioma. SCIN affected cytoskeletal remodeling and inhibited lamellipodia formation through RhoA/FAK signaling pathway, thereby facilitating the migration and invasion of glioma cells. |
| Publish Date |
2024-06-24 08:56 |
| Citation |
<p>Wang X, Luo LX. New targets for cancer promotion and therapy in gliomas: Scinderin. <i>World J Clin Oncol</i> 2024; 15(6): 687-690</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i6/687.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i6.687 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
